Drugs Controller General of India

New Delhi : The Drugs Controller General of India (DCGI) on Thursday granted regular market approval for Covid vaccines - Covishield and Covaxin - for use in adult population with certain conditions.Bharat Biotech's Covaxin and Serum…

Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, COVID 19, Novel Coronavirus, Fight Against Corona, Oxygen, Oxygen Cylinders, SARS-CoV-2, Oxygen Plants, Oxygen Concentrator, Oxygen supply, Liquid Medical Oxygen, Oximeter,…

Mumbai-based pharma company Cipla will add Moderna to the list of Covid-19 vaccines available in India for restricted emergency use.Sources said that the company has received permission from Drugs Controller General of India (DCGI) to…

Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of Covid-19.Biophore has…

The Drugs Controller General of India (DCGI) has accorded permission to conduct the Phase II-III clinical trial of Covaxin (Covid vaccine) in the age group of two to 18-years-old to its manufacturer Bharat Biotech Ltd, Union Health Ministry…

Biological E. Ltd (BE), a Hyderabad-based vaccines and pharmaceutical company, on Monday announced that it has initiated clinical trial of its Covid-19 subunit vaccine candidate in the country following approval from the Drugs Controller…

 Leading pharmaceutical company Bharat Biotech will use Kansas-based ViroVax's adjuvant Alhydroxiquim-II to boost the immune response to its coronavirus vaccine Covaxin.Covaxin is an inactivated vaccine derived from a strain of SARS-CoV-2…

Hyderabad-based Zenara Pharma on Wednesday announced that it has received approval from the Drugs Controller General of India (DCGI) to manufacture and sell Favipiravir tablets as a treatment option for patients with mild to moderate…

Mumbai : The national and international media is abuzz with two possible Indian vaccines against the COVID-19. The Drugs Controller General of India (DCGI) approved - COVAXIN of Hyderabad based Bharat Biotech and ZyCoV-D of Ahmedabad based…